Clinical Trial Update: A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis [Phase 3]

View source ↗

Summary

A Phase 3 trial in China tested nintedanib for progressive lung fibrosis, with results posted in May 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Progressive Fibrosing Interstitial Lung Disease

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Lung Diseases, Interstitial | Phase 3 | Status: COMPLETED | Results posted: 2025-05-20